Part 2 court-adjudicated adult incapacity

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.15(a)(1) says that when a court has adjudicated a patient as lacking capacity, for a reason other than insufficient age, to make their own health-care decisions, the personal representative may give any consent required by Part 2. Current section 2.31 governs a written consent. The HHS fact sheet identifies February 16, 2026 as the compliance date for the 2024 amendments.

The court order defines the capacity finding

Current 42 CFR 2.15 distinguishes judicial adjudication from temporary medical incapacity without adjudication. Preserve the court, case, patient, finding, health-care decision scope, excluded age basis, effective date, duration, review, and certified order.

Capacity can be decision-specific

An order may address all health-care decisions or a narrower area. Treatment consent, Part 2 use or disclosure consent, records access, payment, litigation, research, and financial decisions can have different authority. Read the actual instrument.

Verify continuing status before action

Check modification, appeal, restoration, expiration, successor representative, jurisdiction change, conflict, abuse or endangerment concern, and state-law requirements. Give the patient understandable information and participation opportunities appropriate to the situation.

Authenticate the adjudication and current representative

Obtain the operative signed or certified order through a trusted source. Record court, jurisdiction, case, patient, finding, reason, covered decisions, representative, restrictions, start date, duration, review date, and later modification. Verify representative identity and current appointment independently before discussing protected information.

A diagnosis, clinical capacity note, power of attorney, caregiver role, emergency-contact label, or family statement may be important without establishing the court adjudication described in paragraph (a)(1). Route unclear or foreign orders, appeals, restoration proceedings, successor appointments, and competing claims to experienced counsel.

Map the order to the proposed Part 2 action

Describe the exact recipient, information, purpose, date range, use or disclosure, and consent requested. Determine whether the order and applicable law give this representative authority for that health-care decision. General financial, litigation, or estate authority may not answer a health-care consent question.

Then complete every applicable consent element, including patient, recipient, information, purpose, expiration, revocation, signature, date, and required statements. A representative's broad appointment does not make the consent indefinite or authorize unrelated records and recipients.

Protect participation, preference, and safety

Give the patient accessible information and a meaningful opportunity to express preferences, assent, objection, or concerns when possible. Use interpreters, communication supports, extra time, and a trusted supporter consistent with safety and law. Record the patient's communication separately from the representative's legal decision.

Screen conflicts, abuse, neglect, exploitation, coercion, and endangerment. Use safeguarding, ethics, clinical, privacy, and legal escalation when the representative's request appears inconsistent with the patient's welfare or actual authority.

Recheck before disclosure

Store the order, authority scope, expiration, restrictions, and review owner in a controlled record. Configure portal, release, billing, messaging, and vendor access from the verified scope. Revalidate court and representative status before each material disclosure and after any jurisdiction, order, patient-capacity, or representative change.

Build a decision record that exposes missing authority

Use separate fields for the court's capacity finding, the representative's appointment, the proposed Part 2 consent, and the final disclosure. For each, record source, date, scope, restrictions, reviewer, and status. This structure makes it harder for a valid order to be mistaken for a complete disclosure authorization.

Before acting, ask whether the order addresses health-care decisions, whether the named representative is still serving, whether the proposed recipient and purpose fit the representative's authority, whether the consent itself is complete, and whether the patient has regained rights or expressed a safety concern. Record unresolved facts and the person responsible for resolving them.

The patient or supporter can ask for the legal source, the decisions covered, who is acting, how the patient will participate, how objections are handled, and when authority will be reviewed. Provide a privacy or patient-rights contact through a safe channel.

Example

Ten adjudication files are reviewed. Eight have authenticated order, capacity scope, representative, restrictions, effective date, current status, and decision mapping; two contain only a guardian label. Completeness is 8 of 10 files.

Court-adjudication checklist

• authenticate the operative order and every later modification;
• verify identity, appointment, scope, restrictions, duration, and current status;
• map authority to the exact Part 2 consent and disclosure proposed;
• complete all consent elements and limit recipient, purpose, information, and time;
• support patient participation and escalate conflict or safety concerns; and
• enforce and recheck authority across portal, records, billing, messaging, and vendors.

Court language and representative law vary. A guardian label or clinical incapacity assessment alone is not enough for this Part 2 route.